Lantheus Holdings Inc (LNTH) has disclosed a new risk, in the Technology category.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Lantheus Holdings Inc. faces a significant business risk due to potential constraints on the availability of PET scanners, which are essential for the use of their radiopharmaceutical diagnostic products. The company’s growth prospects for PYLARIFY, as well as the successful launch and commercialization of pipeline products like MK-6240 and NAV-4694, are heavily reliant on the market supply of these scanners. Should there be a shortage or limitation in PET scanner capacity, it could materially and adversely affect Lantheus’s business operations, financial condition, and cash flows.
The average LNTH stock price target is $131.88, implying 41.43% upside potential.
To learn more about Lantheus Holdings Inc’s risk factors, click here.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue